3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
11
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Thrombocythemia, Essential
1
Radiation Injuries
1
Primary Myelofibrosis
1
Postoperative Complications
1
Polycythemia Vera
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, B-Cell
1
Low Anterior Resection Syndrome
1
Leukemia, Myelomonocytic, Chronic
1
Hyperthermia
1
Fatigue
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Diathermy
20
Radiotherapy
10
Cisplatin
5
Fluorouracil
4
Drug Therapy
4
Radiation
3
Melphalan
3
Immune Checkpoint Inhibitors
3
Cytoreduction Surgical Procedures
3
Brachytherapy
3
tislelizumab
2
Solutions
2
Immunotherapy
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Doxorubicin
2
Conization
2
Capecitabine
2
spartalizumab
1
sodium thiosulfate
1
anlotinib
1
Temozolomide
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Leucovorin
1
Laser Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hyperthermia
×
Consolidation Chemotherapy
×
Clear all
NCT06831981
2025-02-18
ARO 2024-13
University Hospital Tuebingen
Phase NA
Recruiting
264 enrolled